Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic vs selective LISA in preterm infants
DRKS00028086Phase 3Recruiting
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Poractant alfa in respiratory distress syndrome (RDS), sponsored by Universitätsklinikum Schleswig-Holstein. Started Feb 2022; status: recruiting.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on DRKS00028086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00028086.